Consolidated statements of changes in equity
View as excel [XLS - 35KB]
| Attributable to holders of the parent | ||||||||||||||
| Issued share capital R'000 |
Share premium R'000 |
Non- distributable reserves R'000 |
Retained income R'000 |
Total attributable to ordinary shareholders R'000 |
Non- controlling interests R'000 |
Total R'000 |
||||||||
| As at 1 July 2013 | 16 861 | 524 788 | 467 433 | 2 762 300 | 3 771 382 | 129 801 | 3 901 183 | |||||||
| Share issue | 49 | 7 263 | 7 312 | 7 312 | ||||||||||
| Movement in treasury shares | (32) | (21 131) | (21 163) | (21 163) | ||||||||||
| Movement in share-based payment reserve | 8 825 | 8 825 | 8 825 | |||||||||||
| Acquisition of non-controlling interests in Ayrton Drug Manufacturing Limited | (69) | (69) | (174) | (243) | ||||||||||
| Total comprehensive income | (46 174) | (832 533) | (878 707) | (3 748) | (882 455) | |||||||||
| Loss for the year | (832 533) | (832 533) | 3 764 | (828 769) | ||||||||||
| Other comprehensive income | (46 174) | (46 174) | (7 512) | (53 686) | ||||||||||
| Dividends | (145 010) | (145 010) | (7 301) | (152 311) | ||||||||||
| Share issue expenses incurred by subsidiary | (3 669) | (3 669) | (3 669) | |||||||||||
| Balance at 30 June 2014 (audited) | 16 878 | 510 920 | 426 415 | 1 784 688 | 2 738 901 | 118 578 | 2 857 479 | |||||||
| Share issue | 10 | 2 018 | 2 028 | 2 028 | ||||||||||
| Movement in share-based payment reserve | 16 098 | 16 098 | 16 098 | |||||||||||
| Acquisition of non-controlling interests in Ayrton Drug Manufacturing Limited | (31) | (31) | (101) | (132) | ||||||||||
| Total comprehensive income | 62 487 | 197 932 | 260 419 | (330) | 260 089 | |||||||||
| Profit for the year | 197 932 | 197 932 | 877 | 198 809 | ||||||||||
| Other comprehensive income | 62 487 | 62 487 | (1 207) | 61 280 | ||||||||||
| Disposal of non-controlling interest in Bioswiss (Pty) Limited | (14 101) | (14 101) | ||||||||||||
| Dividends | (4 537) | (4 537) | ||||||||||||
| Balance at 30 June 2015 (audited) | 16 888 | 512 938 | 505 000 | 1 982 589 | 3 017 415 | 99 509 | 3 116 924 | |||||||